Contraction	B:C1140999
Timing	O
Patterns	O
in	O
Patients	O
Treated	O
for	O
Breast	O
Cancer	I:C0007104
Before	O
and	O
After	O
Anthracyclines	O
Therapy	O
.	O

Contraction	O
Timing	O
Patterns	O
in	O
Patients	O
Treated	B:C0087111
for	O
Breast	O
Cancer	I:C0007104
Before	O
and	O
After	O
Anthracyclines	O
Therapy	O
.	O

Contraction	O
Timing	O
Patterns	O
in	O
Patients	O
Treated	O
for	O
Breast	B:C0007104
Cancer	I:C0007104
Before	O
and	O
After	O
Anthracyclines	O
Therapy	O
.	O

Contraction	O
Timing	O
Patterns	O
in	O
Patients	O
Treated	O
for	O
Breast	O
Cancer	I:C0007104
Before	O
and	O
After	O
Anthracyclines	B:C0003234
Therapy	O
.	O

Contraction	O
Timing	O
Patterns	O
in	O
Patients	O
Treated	O
for	O
Breast	O
Cancer	I:C0007104
Before	O
and	O
After	O
Anthracyclines	O
Therapy	B:C0087111
.	O

During	O
the	O
development	O
of	O
heart	B:C0018801
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
,	O
the	O
changes	O
of	O
contraction	O
timing	O
pattern	O
and	O
temporal	O
heterogeneity	O
of	O
segmental	O
contraction	O
happen	O
early	O
and	O
may	O
precede	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
in	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
(	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
)	O
.	O

During	O
the	O
development	O
of	O
heart	O
failure	I:C0018801
(	O
heart	B:C0018801
failure	I:C0018801
)	O
,	O
the	O
changes	O
of	O
contraction	O
timing	O
pattern	O
and	O
temporal	O
heterogeneity	O
of	O
segmental	O
contraction	O
happen	O
early	O
and	O
may	O
precede	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
in	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
(	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
)	O
.	O

During	O
the	O
development	O
of	O
heart	O
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
,	O
the	O
changes	O
of	O
contraction	B:C1140999
timing	O
pattern	O
and	O
temporal	O
heterogeneity	O
of	O
segmental	O
contraction	O
happen	O
early	O
and	O
may	O
precede	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
in	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
(	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
)	O
.	O

During	O
the	O
development	O
of	O
heart	O
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
,	O
the	O
changes	O
of	O
contraction	O
timing	O
pattern	O
and	O
temporal	O
heterogeneity	O
of	O
segmental	B:C0205122
contraction	O
happen	O
early	O
and	O
may	O
precede	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
in	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
(	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
)	O
.	O

During	O
the	O
development	O
of	O
heart	O
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
,	O
the	O
changes	O
of	O
contraction	O
timing	O
pattern	O
and	O
temporal	O
heterogeneity	O
of	O
segmental	O
contraction	B:C1140999
happen	O
early	O
and	O
may	O
precede	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
in	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
(	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
)	O
.	O

During	O
the	O
development	O
of	O
heart	O
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
,	O
the	O
changes	O
of	O
contraction	O
timing	O
pattern	O
and	O
temporal	O
heterogeneity	O
of	O
segmental	O
contraction	O
happen	O
early	O
and	O
may	O
precede	O
both	O
symptomatic	O
heart	B:C0018801
failure	I:C0018801
and	O
the	O
decrease	O
in	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
(	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
)	O
.	O

During	O
the	O
development	O
of	O
heart	O
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
,	O
the	O
changes	O
of	O
contraction	O
timing	O
pattern	O
and	O
temporal	O
heterogeneity	O
of	O
segmental	O
contraction	O
happen	O
early	O
and	O
may	O
precede	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
in	O
left	B:C0428772
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
(	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
)	O
.	O

During	O
the	O
development	O
of	O
heart	O
failure	I:C0018801
(	O
heart	O
failure	I:C0018801
)	O
,	O
the	O
changes	O
of	O
contraction	O
timing	O
pattern	O
and	O
temporal	O
heterogeneity	O
of	O
segmental	O
contraction	O
happen	O
early	O
and	O
may	O
precede	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
in	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
(	O
left	B:C0428772
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
)	O
.	O

In	O
patients	O
treated	B:C0087111
with	O
anthracyclines	O
,	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
of	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
are	O
detected	O
once	O
significant	O
myocardial	O
injury	O
has	O
occurred	O
.	O

In	O
patients	O
treated	O
with	O
anthracyclines	B:C0003234
,	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
of	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
are	O
detected	O
once	O
significant	O
myocardial	O
injury	O
has	O
occurred	O
.	O

In	O
patients	O
treated	O
with	O
anthracyclines	O
,	O
both	O
symptomatic	O
heart	B:C0018801
failure	I:C0018801
and	O
the	O
decrease	O
of	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
are	O
detected	O
once	O
significant	O
myocardial	O
injury	O
has	O
occurred	O
.	O

In	O
patients	O
treated	O
with	O
anthracyclines	O
,	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
of	O
left	B:C0428772
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
are	O
detected	O
once	O
significant	O
myocardial	O
injury	O
has	O
occurred	O
.	O

In	O
patients	O
treated	O
with	O
anthracyclines	O
,	O
both	O
symptomatic	O
heart	O
failure	I:C0018801
and	O
the	O
decrease	O
of	O
left	O
ventricular	I:C0428772
ejection	I:C0428772
fraction	I:C0428772
are	O
detected	B:C0442726
once	O
significant	O
myocardial	O
injury	O
has	O
occurred	O
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
whether	O
changes	O
in	O
the	O
timing	O
of	O
contraction	B:C1140999
can	O
be	O
detected	O
early	O
after	O
anthracyclines	O
therapy	O
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
whether	O
changes	O
in	O
the	O
timing	O
of	O
contraction	O
can	O
be	O
detected	B:C0442726
early	O
after	O
anthracyclines	O
therapy	O
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
whether	O
changes	O
in	O
the	O
timing	O
of	O
contraction	O
can	O
be	O
detected	O
early	O
after	O
anthracyclines	B:C0003234
therapy	O
.	O

The	O
aim	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
whether	O
changes	O
in	O
the	O
timing	O
of	O
contraction	O
can	O
be	O
detected	O
early	O
after	O
anthracyclines	O
therapy	B:C0087111
.	O

Forty	O
-	O
one	O
women	B:C0043210
(	O
50	O
±	O
11	O
years	O
old	O
)	O
with	O
newly	O
diagnosed	O
breast	O
cancer	I:C0007104
were	O
prospectively	O
enrolled	O
in	O
two	O
centers	O
and	O
underwent	O
an	O
echocardiogram	O
before	O
and	O
after	O
anthracyclines	O
.	O

Forty	O
-	O
one	O
women	O
(	O
50	O
±	O
11	O
years	O
old	O
)	O
with	O
newly	O
diagnosed	B:C0011900
breast	O
cancer	I:C0007104
were	O
prospectively	O
enrolled	O
in	O
two	O
centers	O
and	O
underwent	O
an	O
echocardiogram	O
before	O
and	O
after	O
anthracyclines	O
.	O

Forty	O
-	O
one	O
women	O
(	O
50	O
±	O
11	O
years	O
old	O
)	O
with	O
newly	O
diagnosed	O
breast	B:C0007104
cancer	I:C0007104
were	O
prospectively	O
enrolled	O
in	O
two	O
centers	O
and	O
underwent	O
an	O
echocardiogram	O
before	O
and	O
after	O
anthracyclines	O
.	O

Forty	O
-	O
one	O
women	O
(	O
50	O
±	O
11	O
years	O
old	O
)	O
with	O
newly	O
diagnosed	O
breast	O
cancer	I:C0007104
were	O
prospectively	O
enrolled	O
in	O
two	O
centers	O
and	O
underwent	O
an	O
echocardiogram	B:C2243117
before	O
and	O
after	O
anthracyclines	O
.	O

Forty	O
-	O
one	O
women	O
(	O
50	O
±	O
11	O
years	O
old	O
)	O
with	O
newly	O
diagnosed	O
breast	O
cancer	I:C0007104
were	O
prospectively	O
enrolled	O
in	O
two	O
centers	O
and	O
underwent	O
an	O
echocardiogram	O
before	O
and	O
after	O
anthracyclines	B:C0003234
.	O

Peak	B:C1868749
longitudinal	I:C1868749
myocardial	I:C1868749
systolic	I:C1868749
strain	I:C1868749
was	O
measured	O
on	O
the	O
apical	O
four	I:C1302256
-	O
and	O
two	O
-	I:C1302267
chamber	I:C1302267
views	I:C1302267
.	O

Peak	O
longitudinal	I:C1868749
myocardial	I:C1868749
systolic	I:C1868749
strain	I:C1868749
was	O
measured	O
on	O
the	O
apical	B:C1302256
four	I:C1302256
-	O
and	O
two	O
-	I:C1302267
chamber	I:C1302267
views	I:C1302267
.	O

Peak	O
longitudinal	I:C1868749
myocardial	I:C1868749
systolic	I:C1868749
strain	I:C1868749
was	O
measured	O
on	O
the	O
apical	O
four	I:C1302256
-	O
and	O
two	B:C1302267
-	I:C1302267
chamber	I:C1302267
views	I:C1302267
.	O

The	O
time	O
to	O
peak	O
systolic	O
longitudinal	O
strain	O
(	O
TP	O
)	O
,	O
ejection	B:C0812388
time	I:C0812388
(	O
ejection	O
time	I:C0812388
)	O
,	O
isovolumic	O
contraction	O
time	O
(	O
IVCT	O
)	O
,	O
systolic	O
time	O
,	O
and	O
diastolic	O
time	O
were	O
measured	O
using	O
strain	O
curves	O
and	O
Doppler	O
tracings	I:C0013523
and	O
compared	O
before	O
and	O
after	O
anthracyclines	O
.	O

The	O
time	O
to	O
peak	O
systolic	O
longitudinal	O
strain	O
(	O
TP	O
)	O
,	O
ejection	O
time	I:C0812388
(	O
ejection	B:C0812388
time	I:C0812388
)	O
,	O
isovolumic	O
contraction	O
time	O
(	O
IVCT	O
)	O
,	O
systolic	O
time	O
,	O
and	O
diastolic	O
time	O
were	O
measured	O
using	O
strain	O
curves	O
and	O
Doppler	O
tracings	I:C0013523
and	O
compared	O
before	O
and	O
after	O
anthracyclines	O
.	O

The	O
time	O
to	O
peak	O
systolic	O
longitudinal	O
strain	O
(	O
TP	O
)	O
,	O
ejection	O
time	I:C0812388
(	O
ejection	O
time	I:C0812388
)	O
,	O
isovolumic	O
contraction	O
time	O
(	O
IVCT	O
)	O
,	O
systolic	O
time	O
,	O
and	O
diastolic	B:C0012000
time	O
were	O
measured	O
using	O
strain	O
curves	O
and	O
Doppler	O
tracings	I:C0013523
and	O
compared	O
before	O
and	O
after	O
anthracyclines	O
.	O

The	O
time	O
to	O
peak	O
systolic	O
longitudinal	O
strain	O
(	O
TP	O
)	O
,	O
ejection	O
time	I:C0812388
(	O
ejection	O
time	I:C0812388
)	O
,	O
isovolumic	O
contraction	O
time	O
(	O
IVCT	O
)	O
,	O
systolic	O
time	O
,	O
and	O
diastolic	O
time	O
were	O
measured	O
using	O
strain	B:C1868749
curves	O
and	O
Doppler	O
tracings	I:C0013523
and	O
compared	O
before	O
and	O
after	O
anthracyclines	O
.	O

The	O
time	O
to	O
peak	O
systolic	O
longitudinal	O
strain	O
(	O
TP	O
)	O
,	O
ejection	O
time	I:C0812388
(	O
ejection	O
time	I:C0812388
)	O
,	O
isovolumic	O
contraction	O
time	O
(	O
IVCT	O
)	O
,	O
systolic	O
time	O
,	O
and	O
diastolic	O
time	O
were	O
measured	O
using	O
strain	O
curves	O
and	O
Doppler	B:C0013523
tracings	I:C0013523
and	O
compared	O
before	O
and	O
after	O
anthracyclines	O
.	O

The	O
time	O
to	O
peak	O
systolic	O
longitudinal	O
strain	O
(	O
TP	O
)	O
,	O
ejection	O
time	I:C0812388
(	O
ejection	O
time	I:C0812388
)	O
,	O
isovolumic	O
contraction	O
time	O
(	O
IVCT	O
)	O
,	O
systolic	O
time	O
,	O
and	O
diastolic	O
time	O
were	O
measured	O
using	O
strain	O
curves	O
and	O
Doppler	O
tracings	I:C0013523
and	O
compared	O
before	O
and	O
after	O
anthracyclines	B:C0003234
.	O

The	O
heterogeneity	O
of	O
contraction	B:C1140999
(	O
dyssynchrony	O
)	O
was	O
measured	O
by	O
the	O
SD	O
of	O
the	O
TP	O
of	O
all	O
segments	O
.	O

The	O
heterogeneity	O
of	O
contraction	O
(	O
dyssynchrony	B:C3160936
)	O
was	O
measured	O
by	O
the	O
SD	O
of	O
the	O
TP	O
of	O
all	O
segments	O
.	O

Anthracyclines	B:C0003234
treatment	O
was	O
associated	O
with	O
an	O
increase	O
in	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
and	O
a	O
decrease	O
in	O
TP	O
.	O

Anthracyclines	O
treatment	B:C0087111
was	O
associated	O
with	O
an	O
increase	O
in	O
heart	O
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
and	O
a	O
decrease	O
in	O
TP	O
.	O

Anthracyclines	O
treatment	O
was	O
associated	O
with	O
an	O
increase	O
in	O
heart	B:C0018810
rate	I:C0018810
(	O
heart	O
rate	I:C0018810
)	O
and	O
a	O
decrease	O
in	O
TP	O
.	O

Anthracyclines	O
treatment	O
was	O
associated	O
with	O
an	O
increase	O
in	O
heart	O
rate	I:C0018810
(	O
heart	B:C0018810
rate	I:C0018810
)	O
and	O
a	O
decrease	O
in	O
TP	O
.	O

TP	O
was	O
correlated	O
with	O
heart	B:C0018810
rate	I:C0018810
.	O

TP	O
/	O
ejection	B:C0812388
time	I:C0812388
was	O
independent	O
of	O
heart	O
rate	I:C0018810
and	O
inversely	O
correlated	O
to	O
peak	O
strain	O
both	O
at	O
baseline	O
and	O
after	O
anthracyclines	O
.	O

TP	O
/	O
ejection	O
time	I:C0812388
was	O
independent	O
of	O
heart	B:C0018810
rate	I:C0018810
and	O
inversely	O
correlated	O
to	O
peak	O
strain	O
both	O
at	O
baseline	O
and	O
after	O
anthracyclines	O
.	O

TP	O
/	O
ejection	O
time	I:C0812388
was	O
independent	O
of	O
heart	O
rate	I:C0018810
and	O
inversely	O
correlated	O
to	O
peak	O
strain	B:C1868749
both	O
at	O
baseline	O
and	O
after	O
anthracyclines	O
.	O

TP	O
/	O
ejection	O
time	I:C0812388
was	O
independent	O
of	O
heart	O
rate	I:C0018810
and	O
inversely	O
correlated	O
to	O
peak	O
strain	O
both	O
at	O
baseline	O
and	O
after	O
anthracyclines	B:C0003234
.	O

TP	O
/	O
ejection	B:C0812388
time	I:C0812388
increased	O
after	O
anthracyclines	O
(	O
1.26	O
±	O
0.19	O
to	O
1.31	O
±	O
0.22	O
;	O
P	O
<	O
.001	O
)	O
,	O
and	O
this	O
increase	O
was	O
correlated	O
with	O
the	O
decrease	O
in	O
strain	O
.	O

TP	O
/	O
ejection	O
time	I:C0812388
increased	O
after	O
anthracyclines	B:C0003234
(	O
1.26	O
±	O
0.19	O
to	O
1.31	O
±	O
0.22	O
;	O
P	O
<	O
.001	O
)	O
,	O
and	O
this	O
increase	O
was	O
correlated	O
with	O
the	O
decrease	O
in	O
strain	O
.	O

TP	O
/	O
ejection	O
time	I:C0812388
increased	O
after	O
anthracyclines	O
(	O
1.26	O
±	O
0.19	O
to	O
1.31	O
±	O
0.22	O
;	O
P	O
<	O
.001	O
)	O
,	O
and	O
this	O
increase	O
was	O
correlated	O
with	O
the	O
decrease	O
in	O
strain	B:C1868749
.	O

The	O
increase	O
in	O
TP	O
/	O
ejection	B:C0812388
time	I:C0812388
was	O
due	O
to	O
an	O
increase	O
in	O
IVCT	O
/	O
ejection	O
time	I:C0812388
.	O

The	O
increase	O
in	O
TP	O
/	O
ejection	O
time	I:C0812388
was	O
due	O
to	O
an	O
increase	O
in	O
IVCT	O
/	O
ejection	B:C0812388
time	I:C0812388
.	O

A	O
similar	O
degree	O
of	O
dyssynchrony	B:C3160936
was	O
found	O
at	O
baseline	O
and	O
after	O
anthracyclines	O
.	O

A	O
similar	O
degree	O
of	O
dyssynchrony	O
was	O
found	O
at	O
baseline	O
and	O
after	O
anthracyclines	B:C0003234
.	O

Anthracyclines	B:C0003234
treatment	O
induces	O
an	O
increase	O
in	O
the	O
duration	O
of	O
contraction	O
,	O
mainly	O
by	O
increasing	O
the	O
IVCT	O
.	O

Anthracyclines	O
treatment	B:C0087111
induces	O
an	O
increase	O
in	O
the	O
duration	O
of	O
contraction	O
,	O
mainly	O
by	O
increasing	O
the	O
IVCT	O
.	O

Anthracyclines	O
treatment	O
induces	O
an	O
increase	O
in	O
the	O
duration	O
of	O
contraction	B:C1140999
,	O
mainly	O
by	O
increasing	O
the	O
IVCT	O
.	O

This	O
increase	O
is	O
correlated	O
to	O
the	O
decrease	O
in	O
strain	B:C1868749
and	O
may	O
therefore	O
have	O
additional	O
prognostic	O
value	I:C1514474
.	O

This	O
increase	O
is	O
correlated	O
to	O
the	O
decrease	O
in	O
strain	O
and	O
may	O
therefore	O
have	O
additional	O
prognostic	B:C1514474
value	I:C1514474
.	O

